Insider Transactions Reported by 27 Insiders of bluebird bio, Inc.

Location
Somerville, MA

Insiders trading volume in the past year

bluebird bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jason Cole Chief Strategy & Financial Off $270,937 19 Aug 2022
Gina Consylman Chief Financial Officer $179,225 01 Feb 2022
Jessica Whitten Chief Accounting Officer $81,351 01 Feb 2022
Christopher Krawtschuk Chief Financial Officer $65,001 01 Mar 2024
Anne-Virginie Eggimann Chief Regulatory Officer $60,395 12 Jul 2022
Philip D. Gregory Chief Scientific Officer $48,781 11 Nov 2021
William Baird Chief Financial Officer $32,586 11 Nov 2021
WENDY L. DIXON Director $17,001 11 Nov 2021
DANIEL LYNCH Director $11,377 11 Nov 2021
William R. Sellers Director $5,147 11 Nov 2021
Denice Torres Director $3,897 11 Nov 2021
Michael Cloonan Director $0 02 Jun 2025
Thomas Klima Chief Commercial & Operating Officer $0 -$2,862 -100% 30 May 2025
Charlotte Jones-Burton Director $0 30 May 2025
Richard A. Colvin Chief Medical Officer $0 -$2,762 -100% 30 May 2025
Joseph Vittiglio Chief Business & Legal Officer $0 -$1,759 -100% 30 May 2025
Richard A. Paulson Director $0 30 May 2025
O. James Sterling Chief Financial Officer $0 02 Jun 2025
Nick Leschly Director $0 30 May 2025
Andrew Obenshain President and CEO, Director $0 -$4,246 -100% 30 May 2025
John O. Agwunobi Director $0 30 May 2025
Mark Vachon Director $0 30 May 2025
Najoh Tita-Reid Director $0 30 May 2025
Elisabeth Leiderman Director $0 30 May 2025
Ramy Ibrahim Director 11 Nov 2021
Sarah JS Glickman Director 11 Nov 2021
Marcela Maus V. Director 11 Nov 2021

Recent Insider Transactions by Companies or Individuals for bluebird bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.